Difference between revisions of "DZI20-199-Case-2"

From MGH Learn Pathology
(Updating subject, access, and performer)
(Added status template)
 
Line 61: Line 61:
 
|subject=Z0FBQUFBQmYxUDU3aEl6bVowWW5ZTTQ5NzctZVVZdmVwYzhWQnlmbjRCd2N2ZGNCa1hvY0tPakN4eUFndU5HU0N2eWgyMldHZlpjYkFzY195WlNIWm9IRGh1SGlwdlBFcWc9PQ
 
|subject=Z0FBQUFBQmYxUDU3aEl6bVowWW5ZTTQ5NzctZVVZdmVwYzhWQnlmbjRCd2N2ZGNCa1hvY0tPakN4eUFndU5HU0N2eWgyMldHZlpjYkFzY195WlNIWm9IRGh1SGlwdlBFcWc9PQ
 
|modality=mrxs
 
|modality=mrxs
 +
}}
 +
{{status
 +
|status=active
 +
|requester=Mjf79
 +
|authoredOn=December 12, 2020 05:28:10 PM
 
}}
 
}}

Latest revision as of 13:59, December 9, 2024

DZI20-199-Case-2
Whipple

FX1: Duodenal peritoneal nodule (1st slide) FX3: Cyst wall (2nd slide)

FX3A: Mass to uncinate margin (3rd slide)
FX1: Fibroadipose tissue with hyalinization, no carcinoma seen. (permanent same)

FX3 (cyst wall): Fibrotic cyst wall with chronic inflammation, negative for carcinoma. (Psuedocyst)

FX3A (mass to uncinate margin): High-grade carcinoma, uncinate margin negative, but comes to within 0.2 cm. (Recurrent undifferentiated carcinoma with osteoclastic giant cells, uncinate ngative)
December 31, 1969 7:00:00 PM